Cannabis Industry Journal

FDA Warning Letter to CBD Company Provides Many Lessons for Burgeoning Market

The U.S. Food and Drug Administration (FDA) issued a warning letter to Curaleaf Inc., a multi-billion-dollar market cap company that is publicly traded on the Canadian Securities Exchange. The FDA determined, based upon a review of the company’s website and social media accounts (Facebook and Twitter), that several of Curaleaf’s cannabidiol (CBD) products are misbranded and unapproved new drugs sold […]

Gaps in Standard Property Insurance Can be an Unknown Hazard for Cannabis Businesses

Basic business liability coverage is not enough for those cultivating, selling and distributing cannabis. General liability, property and even commercial renter’s insurance policies all exclude aspects of cannabis operations, leading to significant gaps in coverage. Unfortunately, many cannabis operations purchase traditional property policies, assuming they’re insured. Then, when a claim […]